Genfit S.A.
GNFTNASDAQHealthcare
$8.95
+$0.35(+4.07%)
Market Cap$445680152
P/E Ratio—
52W High$10
52W Low$2.55
Genfit S.A. (GNFT) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
GNFT · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2025Report Date: May 22, 2025EPS Actual
-$0.64
Est. -$0.26 · -148.9%
Revenue
$0.01B
Est. $0.03B · -62.6%
Fiscal Period
Q2 FY2025
FY ends December
Report Date
May 22, 2025
After Market Close
▼ Miss EPS▼ Miss Revenue
GNFT reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.21
Rev. $0.66B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.21
Rev. Est.$0.66B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2026 | Apr 22, 2026 | — | — | — | — | — | — |
| ▼ Q2 FY2025 | May 22, 2025 | -$0.26 | -$0.64 | -148.9% | $0.01B | $0.03B | -62.6% |
| ◌ Q4 FY2024 | Nov 7, 2024 | — | — | — | — | — | — |
| ▲ Q3 FY2024 | Sep 19, 2024 | $0.33 | $0.54 | +62.3% | $0.07B | $0.05B | +28.9% |
| — Q4 FY2023 | Dec 30, 2023 | — | -$0.18 | — | $0.02B | — | — |
| ▼ Q3 FY2023 | Sep 20, 2023 | -$0.32 | -$0.45 | -41.1% | $0.02B | $0.02B | +5.8% |
| — Q3 FY2023 | Jul 13, 2023 | — | -$0.46 | — | $0.01B | — | — |
| — Q4 FY2022 | Dec 31, 2022 | — | -$0.29 | — | $0.01B | — | — |
Q2 FY2026
Apr 22, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2025
May 22, 2025Miss
EPS Actual
-$0.64
EPS Est.
-$0.26
EPS Surpr.
-148.9%
Revenue
$0.01B
Q4 FY2024
Nov 7, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2024
Sep 19, 2024Beat
EPS Actual
$0.54
EPS Est.
$0.33
EPS Surpr.
+62.3%
Revenue
$0.07B
Q4 FY2023
Dec 30, 2023
EPS Actual
-$0.18
EPS Est.
—
EPS Surpr.
—
Revenue
$0.02B
Q3 FY2023
Sep 20, 2023Miss
EPS Actual
-$0.45
EPS Est.
-$0.32
EPS Surpr.
-41.1%
Revenue
$0.02B
Q3 FY2023
Jul 13, 2023
EPS Actual
-$0.46
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q4 FY2022
Dec 31, 2022
EPS Actual
-$0.29
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $-0.24 | $-0.24 | $-0.24 | 1 |
| Q3 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2025 | $1.01 | $1.01 | $1.01 | 1 |
| Q1 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2024 | $1.41 | $1.41 | $1.41 | 1 |
| Q2 FY2024 | $0.31 | $0.31 | $0.31 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2025 | $0.1B | $0.1B | $0.1B | 1 |
| Q4 FY2024 | $0.1B | $0.1B | $0.1B | 1 |
| Q2 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2025 | May 22, 2025 | -148.9% | $4.35 | $4.34 | -0.23% |
| ▲ Q3 FY2024 | Sep 19, 2024 | +62.3% | $4.34 | $4.19 | -3.46% |
| — Q4 FY2023 | Dec 30, 2023 | — | $3.85 | $4.03 | +4.68% |
| ▼ Q3 FY2023 | Sep 20, 2023 | -41.1% | $3.56 | $3.72 | +4.49% |
| — Q3 FY2023 | Jul 13, 2023 | — | $4.00 | $4.10 | +2.50% |
| — Q4 FY2022 | Dec 31, 2022 | — | $4.39 | $4.25 | -3.19% |
| ▲ Q3 FY2022 | Sep 28, 2022 | +71.0% | $3.83 | $3.98 | +3.92% |
| ▲ Q2 FY2022 | Apr 7, 2022 | +252.9% | $3.75 | $3.92 | +4.53% |
Q2 FY2025-0.23%
Report Date
May 22, 2025
EPS Beat/Miss
-148.9%
Price Before
$4.35
Price After
$4.34
Q3 FY2024-3.46%
Report Date
Sep 19, 2024
EPS Beat/Miss
+62.3%
Price Before
$4.34
Price After
$4.19
Q4 FY2023+4.68%
Report Date
Dec 30, 2023
EPS Beat/Miss
—
Price Before
$3.85
Price After
$4.03
Q3 FY2023+4.49%
Report Date
Sep 20, 2023
EPS Beat/Miss
-41.1%
Price Before
$3.56
Price After
$3.72
Q3 FY2023+2.50%
Report Date
Jul 13, 2023
EPS Beat/Miss
—
Price Before
$4.00
Price After
$4.10
Q4 FY2022-3.19%
Report Date
Dec 31, 2022
EPS Beat/Miss
—
Price Before
$4.39
Price After
$4.25
Q3 FY2022+3.92%
Report Date
Sep 28, 2022
EPS Beat/Miss
+71.0%
Price Before
$3.83
Price After
$3.98
Q2 FY2022+4.53%
Report Date
Apr 7, 2022
EPS Beat/Miss
+252.9%
Price Before
$3.75
Price After
$3.92
Avg Beat Reaction+1.66%
Avg Miss Reaction+2.13%
Beat Rate3 / 8 quarters
Largest Move+4.68% (Q4 FY2023)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: GNFT ends December
Genfit S.A. (GNFT) most recently reported earnings on May 22, 2025 for Q2 FY2025, posting EPS of $-0.64 — missing the analyst consensus of $-0.26 by -148.9%. The next GNFT earnings date is expected around September 1, 2026.
Each quarter, investors track GNFT earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. GNFT revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
GNFT's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
GNFT earnings · 5 questionsGenfit S.A.'s next earnings report is expected around September 1, 2026. GNFT typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; GNFT historically reports after market close (AMC).
GNFT earnings datewhen is GNFT earningsGNFT next earnings datewhen does GNFT report earningsGNFT earnings calendar
▸ Source: FMP · Genfit S.A. SEC filings · US GAAP · Genfit S.A. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026